
This photo provided by Revolution Medicines on Wednesday, Aug. 26, 2026 shows packaging for the new pancreatic cancer drug, daraxonrasib, under the brand name Rasonque. (Revolution Medicines via AP)

This photo provided by Revolution Medicines on Wednesday, Aug. 26, 2026 shows packaging for the new pancreatic cancer drug, daraxonrasib, under the brand name Rasonque. (Revolution Medicines via AP)